SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Summer Interns

IP-Watch interns talk about their Geneva experience in summer 2013. 2:42.

Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Latest Comments
  • So simply put, we have the NABP saying that all ph... »
  • The original Brustle decision was widely criticise... »

  • For IPW Subscribers

    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >


    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >

    Most-Read IP-Watch Stories Of 2012: India Pharma, Europe, ACTA, WIPO Technical Assistance, Gene Patents

    Published on 30 December 2012 @ 5:26 pm

    By , Intellectual Property Watch

    As 2012 becomes a memory, it is fair to say that the intellectual property rights discussion shifted over the past year, with trade agreements, over-reaching in copyright and patents, and the provision of technical assistance all falling under increased pressure. At least if the most-read Intellectual Property Watch stories of the year are any indication.

    Among the top most-read stories was coverage of efforts in India to manage patents on pharmaceuticals, including the Indian government’s issuance of its first compulsory licence for a pharmaceutical, the country’s battle between generic and brand name drug producers, and court cases such as Swiss drug maker Novartis’ challenge of the Indian patent law.

    Major developments in Europe also received top following, such as the end of year approval of a European unitary patent and creation of a network of patent courts, and the Parliament’s passage of an orphan works directive. A high-ranking story was about the Pirate Party using the United Nations as a platform to remind policymakers that users own their information.

    The beleaguered Anti-Counterfeiting Trade Agreement (ACTA) received significant attention as well, as it was defeated in Europe and encountered resistance elsewhere.

    The issue of patenting of genetic resources was consistently popular, with stories about the US Supreme Court and the World Intellectual Property Organization.

    And stories about technical assistance to developing countries drew interest, such as a one-sided training session in Africa that was eventually scrapped, and a series of events that dragged WIPO into the heat of US election year politics when it was discovered that WIPO has been giving technology to sanctioned countries like Iran and North Korea. In general, stories about the functioning of WIPO were consistently well read.

    Notably, several stories dating back as far as 2009 held their positions among the most-read, including one in Spanish involving an Argentine professor’s published work and the issue of access to education, and another laying out the broadcasting industry’s arguments for a WIPO broadcasting treaty. A 2011 story about US farmers’ legal battles with Monsanto over seeds also continued to attract significant readership.

    A special directory of government officials working on intellectual property issues in Geneva garnered a lot of traffic, and it is notable that several of the top articles of the year were not news stories but rather opinion pieces from outside experts.

    Surprisingly absent from the top list were the many IP-Watch stories about the World Health Organization. Also seemingly missing is coverage of the highly confidential negotiation of the Trans-Pacific Partnership Agreement (TPP), plus the stunning defeats of the so-called SOPA and PIPA bills in the US at the start of the year.

    Finally, several stories in the global public eye also drew readership numbers at Intellectual Property Watch. These included the Apple-Samsung patent dispute, the impact of Wikileaks founder Julian Assange, and a World Trade Organization dispute settlement case against Australia for its public health law requiring plain packaging for cigarettes sold in the country.

    Broadly speaking, Intellectual Property Watch readers are diverse and well-distributed across the globe. During the past 12 months, we published hundreds of stories on a wide range of topics, with the heaviest emphasis on the international institutions in Geneva. Some stories are placed behind password, for subscribers (free for most developing countries), so access to them is more limited. Yet even some protected stories are among the most-read.

    As we head into 2013, the year ahead looks more interesting than ever for intellectual property rights, as companies and governments place high value on these assets, courts wade deeper into the issues, and users and public interest advocates continue to work to ensure balance in the process. Stay tuned as Intellectual Property Watch brings you the most important stories of 2013 and as always, let us know what you think!

    The Most-Read IP-Watch Stories Of 2012

    India Grants First Compulsory Licence, For Bayer Cancer Drug
    http://www.ip-watch.org/2012/03/12/india-grants-first-compulsory-licence-for-bayer-cancer-drug/

    Europe Reaches Agreement On Unitary Patent
    http://www.ip-watch.org/2012/06/29/europe-reaches-agreement-on-unitary-patent/

    Pirate Party Rep Tells UN Meeting: “F*** You, This Is My Culture!”
    http://www.ip-watch.org/2012/11/07/f-you-this-is-my-culture-pirate-party-rep-tells-un-meeting/

    India’s Generics-Big Pharma Battle Drops Drug Prices, Raises Legal Debate
    http://www.ip-watch.org/2012/05/20/india%E2%80%99s-generics-big-pharma-battle-drops-drug-prices-raises-legal-debate/

    European Parliament Passes Orphan Works Directive
    http://www.ip-watch.org/2012/09/13/european-parliament-passes-orphan-works-directive/

    Novartis Before India’s Supreme Court: What’s Really At Stake?
    http://www.ip-watch.org/2012/03/02/novartis-before-india%E2%80%99s-supreme-court-what%E2%80%99s-really-at-stake/

    US Congressional Committee Cancels Briefing, Blames WIPO Director General
    http://www.ip-watch.org/2012/07/24/us-congressional-committee-cancels-briefing-blames-wipo-director-general/

    Indigenous Peoples Walk Out Of WIPO Committee On Genetic Resources
    http://www.ip-watch.org/2012/02/22/indigenous-peoples-walk-out-of-wipo-committee-on-genetic-resources/

    US Supreme Court Reverses Myriad Decision Allowing Gene Patents
    http://www.ip-watch.org/2012/03/27/us-supreme-court-reverses-myriad-decision-allowing-gene-patents/

    Fast By Senior WIPO Official Raises Old Staff Questions At UN Agency
    http://www.ip-watch.org/2012/05/11/fast-by-senior-wipo-official-raises-old-staff-questions-at-un-agency/

    Un caso sobre derechos de autor en Argentina pone en primer plano el acceso a la educación
    http://www.ip-watch.org/2009/05/18/un-caso-sobre-derechos-de-autor-en-argentina-pone-en-primer-plano-el-acceso-a-la-educacion/

    Broadcasting Industry Makes Case For WIPO Treaty Revival
    http://www.ip-watch.org/2009/05/27/broadcasting-industry-makes-case-for-treaty-revival-at-wipo/

    Inside Views: Patently Wrong – The Jury’s Verdict In Apple v. Samsung
    http://www.ip-watch.org/2012/09/19/patently-wrong-the-jurys-verdict-in-apple-v-samsung/

    Inside Views: The Contributions Of Julian Assange To The Debate On Intellectual Property
    http://www.ip-watch.org/2012/09/08/the-contributions-of-julian-assange-to-the-debate-on-intellectual-property/

    German Ministry Advises Developing Countries Not To Sign ACTA
    http://www.ip-watch.org/2012/05/08/german-ministry-advises-developing-countries-not-to-sign-acta/

    EU Patent, Patent Court Could Finally Be Approved In Coming Weeks
    http://www.ip-watch.org/2012/11/20/eu-patent-patent-court-could-finally-be-approved-in-coming-weeks/

    US, WIPO Training Programme On IP Rights In Africa Comes Under Fire
    http://www.ip-watch.org/2012/02/12/us-wipo-training-programme-on-ip-rights-in-africa-comes-under-fire/

    Ukraine WTO Trademark Dispute Vs. Australia Tests Public Health Measures
    http://www.ip-watch.org/2012/03/14/ukraine-wto-trademark-dispute-vs-australia-tests-public-health-measures/

    New UN Human Rights Council Resolution On Internet Rights
    http://www.ip-watch.org/2012/07/05/new-un-human-rights-council-resolution-on-internet-rights/

    India: Balancing Public And Private Interests In The Intellectual Property Regime
    http://www.ip-watch.org/2012/09/18/india-balancing-public-and-private-interests-in-the-intellectual-property-regime/

    European Parliament Rejects Referral Of ACTA To EU High Court
    http://www.ip-watch.org/2012/03/27/european-parliament-rejects-referral-of-acta-to-eu-high-court/

    A Look At Who’s Who In Geneva IP Policymaking And Beyond
    http://www.ip-watch.org/2012/09/24/a-look-at-whos-who-in-geneva-ip-policymaking-and-beyond/

    Brazil HIV Drug Patent Ruling Allows Generics, Sends Pipeline Process Into Doubt
    http://www.ip-watch.org/2012/03/21/brazil-hiv-drug-patent-ruling-allows-generics-sends-pipeline-process-into-doubt/

    Most EU Members Sign ACTA; SOPA-Style Protests Building
    http://www.ip-watch.org/2012/01/27/most-eu-members-sign-acta-sopa-style-protests-building/

    ACTA: Will It Ever Become A Valid International Treaty?
    http://www.ip-watch.org/2012/09/13/acta-will-it-ever-become-a-valid-international-treaty/

    US Farmers Sue Monsanto Over GMO Patents, Demand Right To Conventional Crops
    http://www.ip-watch.org/2011/03/30/us-farmers-sue-monsanto-over-gmo-patents-demand-right-to-conventional-crops/

    Inside Views: How To Reboot WIPO
    http://www.ip-watch.org/2012/09/12/how-to-reboot-wipo/

    Changes Coming For Open Access To Research In Europe
    http://www.ip-watch.org/2012/04/16/changes-coming-for-open-access-to-research-in-europe/

    Is ACTA Dying And Are G8 Countries Reacting To Its Impending Death?
    http://www.ip-watch.org/2012/04/15/is-acta-dying-and-are-g8-countries-reacting-to-its-impending-death/

    Singapore Builds Patent Capacity Ahead Of New System
    http://www.ip-watch.org/2012/05/17/singapore-builds-patent-capacity-ahead-of-new-system/

    WIPO’s Gurry Discusses Iran/North Korea; Denies Whistleblower Retaliation
    http://www.ip-watch.org/2012/07/20/wipos-gurry-discusses-irannorth-korea-denies-whistleblower-retaliation/

    WIPO Achieves Single Legal Text On Genetic Resources; Indigenous Peoples Back
    http://www.ip-watch.org/2012/02/23/wipo-delegates-reach-single-legal-text-on-genetic-resources-indigenous-peoples-back/

    US Supreme Court Narrows Patentable Subject Matter
    http://www.ip-watch.org/2012/03/21/us-supreme-court-narrows-patentable-subject-matter/

    US IP Officials Blast NGOs In Geneva
    http://www.ip-watch.org/2012/12/16/us-ip-officials-blast-ngos-in-geneva-trying-to-change-views-on-ip/

    Divergent Approaches To Copyright Reform Emerge In Europe
    http://www.ip-watch.org/2012/08/03/divergent-approaches-to-copyright-reform-emerge-in-europe/

    US Cracks Down On Download Sites In Midst Of Anti-Piracy Debate
    http://www.ip-watch.org/2012/01/21/us-cracks-down-on-download-sites-in-midst-of-anti-piracy-debate/

    William New may be reached at wnew@ip-watch.ch.

     


    Leave a Reply

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website. By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

    By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

    2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

    3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

    4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

    5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

    6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

    7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

    8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

    9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

     

     
    Your IP address is 105.156.110.246